Valeant Pharmaceuticals International Inc (NYSE:VRX)

233.27
Delayed Data
As of May 21
 +4.80 / +2.10%
Today’s Change
106.00
Today|||52-Week Range
235.00
+63.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues2.0B2.1B2.3B2.2B
 
 
 
 
 
Cost of Goods Sold543.5M514.6M537.1M532.9M
 
 
 
 
 
Depreciation And Amortization407.7M406.9M434.3M407.0M
 
 
 
 
 
 
Operating ExpensesGross Income1.1B1.1B1.3B1.3B
 
 
 
 
 
General Expenses582.2M563.2M583.6M629.6M
 
 
 
 
 
Other Operating Expenses0.000.000.006.1M
 
 
Research And Development66.5M59.1M59.1M55.8M
 
 
 
 
 
Total Operating Expenses1.5B1.5B1.6B1.6B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income507.7M571.5M725.0M615.3M
 
 
 
 
 
Extraordinary Credit----28.9M0.00
 
 
Extraordinary Charge-153.0M-140.0M-138.7M-91.9M
 
 
 
 
 
Interest Expense On Debt241.2M258.4M223.7M297.8M
 
 
 
 
 
Other Expenses6.3M202.8M198.6M-71.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income121.0M376.7M590.1M155.4M
 
 
 
 
 
Income Taxes-1.0M-100.3M-56.0M-80.9M
 
 
 
 
 
Minority Interest-3.8M-1.0M-800.0K-800.0K
 
 
 
 
 
Net Income125.8M275.4M534.9M73.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS335.3M335.4M335.8M336.8M
 
 
 
 
 
Shares To Calculate EPS Diluted341.3M341.3M341.9M343.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.38$0.82$1.59$0.22
 
 
 
 
 
EPS Diluted$0.37$0.81$1.56$0.21
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account